Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;35(10):1701-1711.
doi: 10.1002/mds.28284.

Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic

Collaborators, Affiliations

Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic

Anhar Hassan et al. Mov Disord. 2020 Oct.

Abstract

Background: The COVID-19 pandemic restricted usual healthcare management for movement-disorders patients, with a consequent upsurge in telemedicine to bridge the gap.

Objective: To assess global telemedicine usage in the context of the pandemic.

Methods: The Movement Disorder Society (MDS) Telemedicine Study Group surveyed telemedicine experts from 40 countries across all continents in March-April 2020. Four domains of telemedicine were assessed: legal regulations, reimbursement, clinical use, and barriers; comparing emerging responses to the pandemic versus the baseline scenario.

Results: All forms of telemedicine for movement disorders increased globally, irrespective of country income categorization, as an immediate response to the pandemic. This was aided by widespread availability of technology and updated government regulations. However, privacy concerns, lack of reimbursement, limited access, and lack of telemedicine training were barriers highlighted worldwide.

Conclusions: Questions remain about the longevity and extent of changes in regulations and reimbursement regarding telemedicine in the aftermath of the pandemic. © 2020 International Parkinson and Movement Disorder Society.

Keywords: coronavirus; legislation; license; reimbursement; technology; telehealth.

PubMed Disclaimer

References

    1. Papa SM, Brundin P, Fung VSC, et al. Impact of the COVID‐19 pandemic on Parkinson's disease and movement disorders. Mov Disord 2020;35:711–715. - PMC - PubMed
    1. Ben‐Pazi H, Beni‐Adani L, Lamdan R. Accelerating telemedicine for cerebral palsy during the COVID‐19 pandemic and beyond. Front Neurol 2020;11:746. - PMC - PubMed
    1. Cubo EHA, Bloem BR, Mari Z. MDS‐telemedicine study group. Implementation of telemedicine for urgent and ongoing healthcare for patients with Parkinson's disease during the COVID‐19 pandemic: new expectations for the future. J Parkinsons Dis 2020;10(3):911–913. - PubMed
    1. Hassan A, Dorsey ER, Goetz CG, et al. Telemedicine use for movement disorders: a global survey. Telemed J E Health 2018;24:979–992. - PubMed